Mackenzie Financial Corp Purchases 61 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Mackenzie Financial Corp raised its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,353 shares of the biotechnology company’s stock after purchasing an additional 61 shares during the quarter. Mackenzie Financial Corp’s holdings in Axon Enterprise were worth $1,641,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Sands Capital Management LLC raised its position in Axon Enterprise by 31.1% in the third quarter. Sands Capital Management LLC now owns 2,612,305 shares of the biotechnology company’s stock valued at $519,823,000 after purchasing an additional 619,179 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Axon Enterprise by 3.3% during the third quarter. Wellington Management Group LLP now owns 1,956,022 shares of the biotechnology company’s stock worth $389,229,000 after acquiring an additional 62,324 shares during the last quarter. Bank of New York Mellon Corp raised its position in shares of Axon Enterprise by 28.3% during the third quarter. Bank of New York Mellon Corp now owns 726,400 shares of the biotechnology company’s stock worth $144,546,000 after acquiring an additional 160,359 shares during the last quarter. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after acquiring an additional 451,350 shares during the last quarter. Finally, Northern Trust Corp raised its position in shares of Axon Enterprise by 3.1% during the third quarter. Northern Trust Corp now owns 631,212 shares of the biotechnology company’s stock worth $125,605,000 after acquiring an additional 19,068 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Trading Up 2.6 %

Shares of Axon Enterprise stock opened at $301.56 on Wednesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The stock has a 50 day moving average price of $302.15 and a two-hundred day moving average price of $260.29. The stock has a market capitalization of $22.76 billion, a PE ratio of 131.11 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million during the quarter, compared to analysts’ expectations of $418.97 million. As a group, equities analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AXON has been the subject of a number of analyst reports. JMP Securities raised their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a research report on Tuesday, February 6th. Needham & Company LLC raised their price objective on Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Robert W. Baird raised their target price on Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Finally, JPMorgan Chase & Co. raised their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $312.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.